New ASCO Guidelines Address HER2-Positive Breast CancerNew ASCO Guidelines Address HER2-Positive Breast Cancer

New ASCO guidelines recommend HER2-targeted therapy for most patients with HER2-positive advanced breast cancer, using trastuzumab, pertuzumab, and taxane for first-line treatment. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news